GEODON - PFIZER

Basis for Selection:

Pfizer has identified these patents as covering their prescription drug GEODON. If the patents are found to be invalid, generics of the drug can be approved and sold.

Guideline Patent Number: 4,831,031 | Latest Date for Prior Art: March 01, 1986

Guideline Patent Filing Date: January 22, 1988| Owner(s): Pfizer Inc.

Interested Parties: none

Multiple Patent Study Description:

These patents are combined in one study because the patent owner has identified them as covering the prescription drug GEODON. They relate to the structure, formulations and uses of ziprasidone. They are not related as divisionals or continuations to each other. Therefore, each patent has a different date for determining prior art. Please see the details section for each patent for the applicable Latest Date for Prior Art.

Description:

The active ingredient of GEODON is Ziprasidone or
Ziprasidone hydrochloride. The molecular formulae are:
C21-H21-Cl-N4-O-S
C21-H21-Cl-N4-O-S.Cl-H
It is also also known by the synonyms Geodon and Zeldox.
The systematic name is 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride.

The patents relate to the structure, compositions, formulations and methods of use of ziprasidone.

This is a Multiple Patent Study

You can view the included patents below:
Patent #: 4,831,031 (View Details | PDF | Word)
Patent #: 5,312,925 (View Details | PDF | Word)
Patent #: 6,150,366 (View Details | PDF | Word)
Patent #: 6,245,766 (View Details | PDF | Word)